Andorra

Reimbursed Care Access

Andorra maintains strict national drug control laws that criminalize possession, consumption and trafficking of controlled psychoactive substances; there is no public, nationwide reimbursement program for psychedelic-assisted therapies and no evidence of authorized, reimbursed access to classic psychedelics outside regulated research. Certain pharmaceutical derivatives with formal regulatory approvals in the EU (e.g., esketamine/Spravato) are authorized at the European level but there is no clear evidence of routine public reimbursement or formal national programmatic access in Andorra. All other listed classic psychedelic compounds are subject to strict control with no authorized medical use outside approved clinical research or exceptional importation under medical protocols.